Open access
Aug 2026
Highlights from the 2025 ASH meeting: what’s new in lymphoma?
In essence, ASH2025 provided important data for further optimization of regimens including BsAb, targeted therapeutics, and reduced chemotherapy, especially in high-risk and older or unfit patients with lymphoma.
Maike Stegemann, Clemens A. Schmitt
· memo - Magazine of European... · 0 citations